RS
Ramanathan Srinivasa Manickam
About Ramanathan Srinivasa Manickam
Data last updated:
Ramanathan Srinivasa Manickam is a Whole-Time Director at Muthu Pharma Private Limited (since 2019), Director at Rau And Co Pharma Private Limited (since 2023) and Director at Pearl Medicals Private Limited (since 2024), and holds 1 more current directorship. The companies operate in Pharma. The 4 current companies with reported revenue have a combined latest revenue of ₹355 Cr; the largest is Muthu Pharma Private Limited at ₹235 Cr (FY 2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Muthu Pharma Private Limited U51909MH2016PTC449216 | Whole-Time Director | 15 Jun 2019 | 2016 | ₹235 Cr (FY 2022) | Active |
| Rau And Co Pharma Private Limited U51109MH2016PTC449215 | Director | 27 Feb 2023 | 2016 | ₹56.94 Cr (FY 2022) | Active |
| Pearl Medicals Private Limited U85120MH1999PTC449218 | Director | 22 Jun 2024 | 1999 | ₹46.69 Cr (FY 2022) | Active |
 Shell Pharmaceuticals Private Limited U51909MH2009PTC449217 | Director | 27 Feb 2023 | 2009 | ₹16.43 Cr (FY 2022) | Active |
Board colleagues of Ramanathan Srinivasa Manickam
| Name | DIN | Company | Designation |
|---|---|---|---|
| Darshan Anil Haria | 10739987 | Muthu Pharma Private Limited , Rau And Co Pharma Private Limited and 2 more | Additional Director |
| Harshal Ashok Chaudhari | 11224417 | Muthu Pharma Private Limited , Rau And Co Pharma Private Limited and 2 more | Director |
| Praveen Mishra | 08691088 | Muthu Pharma Private Limited , Shell Pharmaceuticals Private Limited | Additional Director |
| Rajaganesan Rajbalaji | 09636145 | Muthu Pharma Private Limited , Shell Pharmaceuticals Private Limited | Additional Director |
| Sanjeevi Gurugopi | 09366298 | Rau And Co Pharma Private Limited | Director |
| Manthan Bhavin Kothari | 08691102 | Pearl Medicals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ramanathan Srinivasa Manickam
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ramanathan Srinivasa Manickam
Ramanathan Srinivasa Manickam currently holds 4 directorships: Muthu Pharma Private Limited (Whole-Time Director, since 15 Jun 2019, revenue ₹235 Cr (FY 2022)); Rau And Co Pharma Private Limited (Director, since 27 Feb 2023, revenue ₹56.94 Cr (FY 2022)); Pearl Medicals Private Limited (Director, since 22 Jun 2024, revenue ₹46.69 Cr (FY 2022)); Shell Pharmaceuticals Private Limited (Director, since 27 Feb 2023, revenue ₹16.43 Cr (FY 2022)).
Ramanathan Srinivasa Manickam was first appointed on 15 Jun 2019 as Whole-Time Director at Muthu Pharma Private Limited. The most recent appointment on record is 22 Jun 2024 at Pearl Medicals Private Limited.
The 4 current companies of Ramanathan Srinivasa Manickam that report revenue have a combined latest revenue of ₹355 Cr: Muthu Pharma Private Limited ₹235 Cr (FY 2022); Rau And Co Pharma Private Limited ₹56.94 Cr (FY 2022); Pearl Medicals Private Limited ₹46.69 Cr (FY 2022); Shell Pharmaceuticals Private Limited ₹16.43 Cr (FY 2022).
The current boards of Ramanathan Srinivasa Manickam's companies include Darshan Anil Haria (Muthu Pharma Private Limited), Harshal Ashok Chaudhari (Muthu Pharma Private Limited), Praveen Mishra (Muthu Pharma Private Limited), Rajaganesan Rajbalaji (Muthu Pharma Private Limited), Sanjeevi Gurugopi (Rau And Co Pharma Private Limited), Manthan Bhavin Kothari (Pearl Medicals Private Limited).